Renal Denervation by Iberis MultiElectrode Renal Denervation System in Patients With Primary Hypertension

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 216 participants.

Also called NCT02901704

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 216 participants (planned count) (from the registry)
Sponsor
Shanghai AngioCare Medical (from the registry)
Registry
  • NCT NCT02901704
Other papers using this trial's data
  • Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial Circulation, 2024-11-12 DOI, PubMed 39229700, PMC11548818 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02901704. Randomized; single masking; primary purpose treatment. Start 2016-12 (registry gives no type); primary completion 2018-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Renal Denervation by Iberis MultiElectrode Renal Denervation System in Patients With Primary Hypertension
Acronym
Iberis-HTN
Condition
Primary Hypertension
Intervention (Device)
Renal Denervation System (AngioCare)
Intervention (Procedure)
Sham procedure
Lead sponsor
Shanghai AngioCare Medical (class: industry)

Record details

Record id
cardio:ct-nct02901704
Content hash
84bc901e6d870ca08b21c316baca3398dc5b6009e493a05a0ec0e44caee6fa95